Scientists at Utah State University Receive Grants to Study Two Important Viruses

Posted on

Researchers at Utah State University, led by Professor Zhongde Wang and collaborating with teams at University of Texas Medical Branch and University of Pittsburgh, respectively, have secured two grants from the National Institutes of Health (NIH) totaling more than $4 million in recent months to advance the understanding of two important global health threats. In […]

Read More

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

Posted on

SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah Governor Cox and the Governor’s Office of Economic Opportunity, as part of the latest World Trade Center (WTC) Utah trade […]

Read More

BioUtah Member BBQ Recap

BioUtah’s annual membership appreciation BBQ was held yesterday at the Gateway’s Hidden Gem Patio. The event was a great way for the nearly 200 registrants to network with colleagues and make new connections. Prior to the BBQ, an executive reception was held, with several BioUtah Board members present. Also, in conjunction with the BBQ, the […]

Read More

ATL Technology Acquires Catheter Technologies Firm MDCM Solutions

Posted on

SPRINGVILLE, UT, UNITED STATES, August 26, 2024 /EINPresswire.com/ — ATL Technology, a global leader in medical device development and manufacturing, announced today its acquisition of MDCM Solutions, a Minnesota manufacturing company specializing in complex catheter technologies used in the manufacture of minimally invasive medical devices. The newly acquired ATL Minnesota site will serve as a […]

Read More

VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon Biosciences

Posted on

CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION […]

Read More

Ultradent Announces Majority Stake in i-dental

Posted on

Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials, is announcing acquisition of Medicinos Linija UAB, known globally as “i-dental,” a renowned manufacturer and distributer of dental products headquartered in Siauliai, Lithuania. The addition of i-dental’s network and infrastructure will assist Ultradent’s ability to better serve dentists throughout the world. With i-dental […]

Read More

Arieli Capital Joins Induction Bio as a Partner and Announces the Establishment of the Induction Reproductive Health Studio – IDEAS

Posted on

Reproductive Healthcare Studio focused on advancing pioneering research, developing innovative technologies and building startups that aim to transform reproductive health and fertility HERZLIYA, Israel and SALT LAKE CITY, Utah, July 31, 2024 /PRNewswire/ — Induction Bio, LLC (Induction), a reproductive healthcare company, and Arieli Capital, LLC (Arieli), a multifaceted global investment firm, today announced that Arieli […]

Read More

Utah Innovation Fund Invests in Purgo Scientific

Posted on

Utah Innovation Fund is pleased to announce its recent investment in Purgo Scientific, a De Novo biotech firm with a mission to revolutionize treatment of surgical site infections. The Salt Lake City-based startup is Utah Innovation Fund’s seventh investment to date out of its $30M state-backed fund. “What’s unique about Purgo is their focus on […]

Read More

Turner MedTech Joins the Prestigious Inc. 5000 List

Posted on

Orem, Utah – August 13, 2024 Turner MedTech, a leading innovator in the medical device and biotechnology sector, is proud to announce its inclusion in the esteemed Inc. 5000 list, a hallmark of entrepreneurial success. The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its […]

Read More

EDWARDS LIFESCIENCES EXPANDS STRUCTURAL HEART PORTFOLIO WITH ACQUISITIONS OF JENAVALVE AND ENDOTRONIX

Posted on

IRVINE, Calif.–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. Edwards has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), a […]

Read More